Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

35.34 +0.52 (+1.49%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,663,983
Open 34.61
Bid (Size) 35.00 (100)
Ask (Size) 35.62 (200)
Prev. Close 34.82
Today's Range 34.21 - 35.78
52wk Range 28.66 - 117.33
Shares Outstanding 115,926,629
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Rosen Law Firm Urges Corcept Therapeutics Incorporated (NASDAQ: CORT) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
CORCEPT THERAPEUTICS INCORPORATED (CORT) INVESTOR ALERT Investors With Large Losses in Corcept Therapeutics Incorporated Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire

Performance

YTD
-7.5%
-7.5%
1 Month
-19.6%
-19.6%
3 Month
-54.5%
-54.5%
6 Month
-48.6%
-48.6%
1 Year
-42.8%
-42.8%

More News

Read More
News headline image
CORT Investors Notified of Investigation Into Corcept Therapeutics, Inc. by Kaplan Fox
Via NewMediaWire
News headline image
CORT Investors Notified of Investigation Into Corcept Therapeutics, Inc. by Kaplan Fox
Via TheNewswire.com
Corcept Therapeutics Inc (NASDAQ:CORT) Presents a Compelling GARP Investment Case ↗
Via Chartmill
News headline image
Corcept (CORT) Q4 Earnings: What To Expect
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
Kaplan Fox is Investigating Possible Securities Law Violations Against Corcept Therapeutics, Inc. (CORT)
Via NewMediaWire
News headline image
Kaplan Fox is Investigating Possible Securities Law Violations Against Corcept Therapeutics, Inc. (CORT)
Via TheNewswire.com
News headline image
Investor Alert: Robbins LLP Informs Investors of the Corcept Therapeutics Inc. Class Action Lawsuit
From Robbins LLP
Via Business Wire
News headline image
Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations
Via NewMediaWire
News headline image
Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations
Via TheNewswire.com
News headline image
Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals
From Corcept Therapeutics Incorporated
Via Business Wire
News headline image
CORT Stock Drops After Appeals Court Sides With Teva In Korlym Patent Fight ↗
Via Stocktwits
Topics Intellectual Property
News headline image
CORT ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Corcept Therapeutics, Inc. (CORT) for Possible Securities Law Violations
Via TheNewswire.com
News headline image
CORT ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Corcept Therapeutics, Inc. (CORT) for Possible Securities Law Violations
Via NewMediaWire
News headline image
CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
CORCEPT THERAPEUTICS ALERT: Corcept Therapeutics, Inc. (CORT) are Encouraged to Contact Kaplan Fox Regarding Potential Securities Law Violations
Via NewMediaWire
News headline image
CORCEPT THERAPEUTICS ALERT: Corcept Therapeutics, Inc. (CORT) are Encouraged to Contact Kaplan Fox Regarding Potential Securities Law Violations
Via TheNewswire.com
News headline image
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results, Provide Corporate Update and Host Conference Call
From Corcept Therapeutics Incorporated
Via Business Wire
News headline image
CORT SECURITIES INVESTIGATION: Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations
Via TheNewswire.com
News headline image
CORT SECURITIES INVESTIGATION: Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations
Via NewMediaWire
News headline image
CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
3 Small-Cap Stocks We Think Twice About
Via StockStory
News headline image
3 Cash-Producing Stocks We’re Skeptical Of
Via StockStory
News headline image
CORCEPT THERAPEUTICS SECURITIES INVESTIGATION: Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations
Via NewMediaWire

Frequently Asked Questions

Is Corcept Therapeutics Incorporated - Common Stock publicly traded?
Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.
What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?
Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?
The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market
What is the current price of Corcept Therapeutics Incorporated - Common Stock?
The current price of Corcept Therapeutics Incorporated - Common Stock is 35.34
When was Corcept Therapeutics Incorporated - Common Stock last traded?
The last trade of Corcept Therapeutics Incorporated - Common Stock was at 02/23/26 04:00 PM ET
What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?
The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 4.10B
How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?
Corcept Therapeutics Incorporated - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.